Every week, Artnet News brings you
. The column decodes important stories from the previous week and offers unparalleled insight into the inner workings of the art industry in the process.
In the final Monday edition of this column, which is moving permanently to Wednesdays (yes, really) starting next week, let’s consider how a cure can divide markets as surely as a disease…
INJECTING APPEAL
As vaccination campaigns ramp up around the United States, more and more businesses are trying to do well by doing good in a whole new way: by offering special perks to consumers who can prove they’ve been inoculated against everyone’s least favorite spike protein. But while a broadening range of national corporations and local entrepreneurs are joining in the effort, so far there seems to be little interest from inside the art industry another subtle reminder that connecting with a wide audience rarely rates as a priority in the realm of high culture.